Your session is about to expire
← Back to Search
Behavioral Intervention
IDS Interventions for Infant Development
N/A
Waitlist Available
Research Sponsored by Northwestern University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Must speak English or Dagbani (a language local to Tamale and the surrounding areas)
Must be age 18 to 40 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 10 hours
Awards & highlights
Study Summary
This trial is testing whether or not talking to infants encourages language and brain development.
Who is the study for?
This trial is for women aged 18-40 in Tamale, Ghana, who are pregnant or have infants aged 2-18 months. Participants must visit local health facilities and speak English or Dagbani. It's designed to help mothers learn how to improve their babies' language and brain development through talking.Check my eligibility
What is being tested?
The study tests a simple strategy using videos and wall calendars to encourage mothers to engage more with their infants through infant-directed speech (IDS), which could benefit the child's early development.See study design
What are the potential side effects?
There are no medical side effects associated with this intervention as it involves educational materials rather than medication or clinical treatments.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I speak English or Dagbani.
Select...
I am between 18 and 40 years old.
Select...
I am between 2 and 18 months old.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 10 hours
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~10 hours
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Adult word count
Number of conversational turns
Self-reported parental IDS behavior (Index)
+1 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Infant Directed Speech (IDS) Video + IDS CalendarExperimental Treatment1 Intervention
The participant will be shown a 3-minute video describing the value of IDS and how the participant can use IDS with their child. The participant will receive an IDS-themed wall calendar.
Group II: ControlActive Control1 Intervention
No intervention. The participant will receive a regular wall calendar with an image of Stanford.
Find a Location
Who is running the clinical trial?
Northwestern UniversityLead Sponsor
1,585 Previous Clinical Trials
914,431 Total Patients Enrolled
1 Trials studying Infant Development
350 Patients Enrolled for Infant Development
Seema JayachandranLead Sponsor
Stanford UniversityOTHER
2,393 Previous Clinical Trials
17,338,392 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I speak English or Dagbani.I am between 18 and 40 years old.I am between 2 and 18 months old.
Research Study Groups:
This trial has the following groups:- Group 1: Infant Directed Speech (IDS) Video + IDS Calendar
- Group 2: Control
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Who is the ideal candidate for participation in this medical experiment?
"This medical trial seeks to enrol 2800 individuals aged between 18 and 40 who are experiencing infant development. Additional criteria include: adult women attending government healthcare centres in Tamale, Ghana; must be the biological child or ward of a baseline respondent; age 2-18 months at endline period."
Answered by AI
Is there a recruitment period for participants of this clinical trial?
"Clinicaltrials.gov has recorded that this medical research is not currently seeking participants; its first post was on March 2nd 2021, and the last edit happened on May 9th 2022. Despite no longer being open to applicants, there are 32 other trials with active recruitment happening now."
Answered by AI
Is there an upper age limit to be accepted into this medical trial?
"This trial requires that applicants are aged between 18 and 40. However, there are separate clinical trials for those under the age of 18 or over 65 years old; 26 studies for minors and 6 experiments geared towards seniors."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger